StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
253
This month
4
This week
1
This year
34
Publishing Date
2024 - 04 - 02
2
2024 - 03 - 13
2
2024 - 02 - 22
2
2024 - 02 - 14
3
2024 - 02 - 12
2
2024 - 02 - 10
2
2024 - 01 - 16
3
2023 - 12 - 13
4
2023 - 11 - 22
2
2023 - 07 - 21
2
2023 - 06 - 26
2
2023 - 06 - 02
2
2023 - 05 - 15
3
2023 - 05 - 08
2
2023 - 04 - 27
2
2023 - 04 - 20
3
2023 - 04 - 18
2
2023 - 02 - 22
2
2023 - 01 - 19
2
2023 - 01 - 18
2
2023 - 01 - 09
3
2023 - 01 - 06
2
2022 - 11 - 15
2
2022 - 11 - 07
2
2022 - 10 - 31
3
2022 - 10 - 17
2
2022 - 10 - 11
2
2022 - 10 - 10
2
2022 - 09 - 06
2
2022 - 09 - 05
4
2022 - 08 - 08
3
2022 - 08 - 04
2
2022 - 07 - 28
4
2022 - 06 - 20
3
2022 - 05 - 11
2
2022 - 04 - 26
3
2022 - 04 - 18
1
2022 - 04 - 12
2
2022 - 04 - 11
1
2022 - 04 - 06
1
2022 - 03 - 28
1
2022 - 03 - 18
1
2022 - 03 - 15
1
2022 - 03 - 08
1
2022 - 03 - 07
1
2022 - 02 - 23
1
2022 - 02 - 22
1
2022 - 02 - 17
1
2022 - 01 - 07
1
2021 - 12 - 20
1
2021 - 12 - 14
1
2021 - 12 - 03
1
2021 - 11 - 24
1
2021 - 11 - 12
1
2021 - 11 - 11
1
2021 - 10 - 28
1
2021 - 10 - 22
1
2021 - 10 - 12
1
2021 - 10 - 07
1
2021 - 10 - 04
2
Sector
Commercial services
2
Communications
2
Consumer non-durables
3
Distribution services
1
Electronic technology
2
Finance
1
Health services
5
Health technology
253
Information
1
Manufacturing
22
N/a
6
Process industries
6
Producer manufacturing
2
Professional, scientific, and technical services
3
Tags
Active
5
Advanced
4
Africa
3
Antibody
5
Approval
4
Asco
3
Australia
3
Biocapital
3
Biotech-bay
3
Business
3
Cancer
28
Care
3
Cell
5
China
15
Chinese
15
Clinical-trials-phase-iii
4
Collaboration
6
Companies
19
Covid-19
3
Depression
3
Designation
5
Diabetes
9
Disease
14
Drug
21
Dupixent
4
Expected
14
First
4
Global
57
Growing
9
Growth
45
Ibi351
6
Ibi362
9
Immunotherapy
7
Insulin
13
Liver
5
Lung
7
Market
139
Medical
5
Meeting
10
N/a
230
News
4
Novartis
4
Obesity
9
Phase 1
4
Plus
4
Rapid
4
Reach
9
Report
53
Research
23
Results
13
Sanofi
8
Set
4
Study
37
Therapeutics
16
Therapy
15
Treatment
31
Trial
12
Trials
6
Tumors
7
Tyvyt
4
Entities
Abbott laboratories
219
Abbvie inc.
167
Alnylam pharmaceuticals, inc.
63
Alphabet inc.
32
Amarin corporation plc
31
Amgen inc.
132
Astellas pharma inc
70
Astrazeneca plc
176
Bausch health companies inc.
24
Baxter international inc.
41
Becton, dickinson and company
26
Biogen inc.
48
Biomarin pharmaceutical inc.
19
Biontech se
128
Boston scientific corporation
19
Bristol-myers squibb company
70
Byline bancorp, inc.
26
Csl ltd
22
Denali therapeutics inc.
19
Eli lilly and company
253
Endo international plc
18
Galapagos nv
36
Gilead sciences, inc.
35
Glaxosmithkline plc
272
Icon plc
12
Igm biosciences, inc.
37
Incyte corporation
102
Innate pharma s.a.
81
Innate pharma sa
81
Insulet corporation
15
Johnson & johnson
458
Kymera therapeutics, inc.
22
Medtronic plc
33
Mobiv acquisition corp
65
Moderna, inc.
22
Morgan stanley
14
Morphosys ag
33
Nektar therapeutics
39
Novartis ag
284
Novo nordisk a/s
100
Nurix therapeutics, inc.
14
Oncocyte corporation
32
Orange
49
Pegasus digital mobility acquisition corp.
17
Perrigo company
103
Pfizer, inc.
90
Provention bio, inc.
283
Ptc therapeutics, inc.
30
Rallybio corp
31
Rcf acquisition corp.
83
Reckitt benckiser group plc
20
Regeneron pharmaceuticals, inc.
188
Sanofi
3597
Takeda pharmaceutical company limited
51
Teva pharmaceutical industries limited
17
Teva pharmaceutical industries ltd
224
Therapeuticsmd, inc.
30
Thermo fisher scientific inc
36
Vaxart, inc.
31
Viatris inc.
81
Symbols
ABBV
111
ABCL
12
ABT
56
ACIU
35
ADCT
13
AKUS
11
ALNY
38
ALPMF
25
ALPMY
25
AMGN
88
AVEO
25
AZN
98
AZNCF
81
BAX
14
BCRX
13
BDX
21
BGNE
19
BIIB
20
BMY
106
BNTX
14
BPMC
20
CLVS
20
DTIL
11
EPZM
20
EXEL
13
GILD
35
GLAXF
80
GSK
107
HCM
11
ILMN
15
INCY
207
JNJ
175
KPTI
20
LLY
1709
MDT
14
MRUS
21
NVO
83
NVS
138
NVSEF
121
OMER
15
OTIC
13
PFE
80
PODD
14
PRQR
17
REGN
36
RIGL
41
SNY
335
SNYNF
253
TAK
42
TEVJF
61
TMO
14
TRUMF
14
TRUMY
14
UCBJF
11
UCBJY
11
UTHR
14
VERU
57
VRTX
12
VTRS
18
YMAB
18
Exchanges
Amex
1
Nasdaq
253
Nyse
253
Crawled Date
2024 - 04 - 02
2
2024 - 03 - 13
2
2024 - 02 - 22
2
2024 - 02 - 14
3
2024 - 02 - 12
2
2024 - 02 - 10
2
2024 - 02 - 07
2
2024 - 01 - 16
3
2023 - 12 - 13
4
2023 - 11 - 22
2
2023 - 07 - 21
2
2023 - 06 - 26
2
2023 - 05 - 15
3
2023 - 05 - 08
2
2023 - 04 - 20
3
2023 - 04 - 18
2
2023 - 01 - 19
2
2023 - 01 - 18
2
2023 - 01 - 09
3
2023 - 01 - 06
2
2022 - 11 - 15
2
2022 - 11 - 07
2
2022 - 10 - 31
3
2022 - 10 - 17
2
2022 - 10 - 11
2
2022 - 10 - 10
2
2022 - 09 - 06
2
2022 - 09 - 05
4
2022 - 08 - 08
3
2022 - 08 - 04
2
2022 - 07 - 28
4
2022 - 06 - 20
3
2022 - 05 - 11
2
2022 - 04 - 26
3
2022 - 04 - 25
1
2022 - 04 - 21
1
2022 - 04 - 18
1
2022 - 04 - 12
2
2022 - 04 - 11
1
2022 - 04 - 06
1
2022 - 03 - 28
1
2022 - 03 - 18
1
2022 - 03 - 15
1
2022 - 03 - 08
1
2022 - 03 - 07
1
2022 - 02 - 23
1
2022 - 02 - 22
1
2022 - 02 - 17
1
2022 - 01 - 07
1
2021 - 12 - 20
1
2021 - 12 - 14
1
2021 - 12 - 03
1
2021 - 11 - 24
1
2021 - 11 - 12
1
2021 - 11 - 11
1
2021 - 10 - 28
1
2021 - 10 - 22
1
2021 - 10 - 12
1
2021 - 10 - 07
1
2021 - 10 - 04
2
Crawled Time
00:00
27
00:20
3
01:00
31
02:00
5
03:00
2
04:00
1
04:20
5
05:00
5
06:00
3
07:00
2
08:00
2
09:00
4
10:00
5
11:00
3
12:00
6
12:20
1
12:30
1
13:00
3
13:20
3
13:30
2
14:00
6
14:20
1
14:30
1
15:00
5
15:20
6
15:30
4
16:00
29
17:00
12
18:00
11
19:00
13
20:00
8
21:00
21
22:00
15
23:00
7
Source
www.biospace.com
23
www.globenewswire.com
5
www.prnewswire.com
225
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Eli lilly and company
symbols :
SNYNF
save search
89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
Published:
2024-04-17
(Crawled : 20:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.0%
|
O:
0.0%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-0.11%
|
O:
-1.81%
H:
0.0%
C:
0.0%
biotech
Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight
Published:
2024-04-09
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.65%
|
O:
-0.01%
H:
0.0%
C:
0.0%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-7.54%
|
O:
-2.01%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-4.08%
|
O:
-0.71%
H:
0.0%
C:
0.0%
BIO
|
$279.73
-0.46%
0.0%
290K
|
Health Technology
|
-17.6%
|
O:
-2.71%
H:
0.52%
C:
0.24%
AVTR
|
$24.1
-0.82%
0.25%
4.7M
|
Process Industries
|
-6.81%
|
O:
-1.7%
H:
1.08%
C:
0.55%
THMO
|
$0.6695
3.0%
2.91%
8.6K
|
Health Technology
|
-20.61%
|
O:
4.99%
H:
2.78%
C:
-2.1%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.59%
|
O:
-0.32%
H:
0.0%
C:
0.0%
global
growth
market
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published:
2024-04-02
(Crawled : 05:00)
- prnewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-6.49%
|
O:
-2.79%
H:
1.32%
C:
1.18%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.05%
|
O:
-1.14%
H:
0.02%
C:
-1.06%
review
cancer
treatment
advanced
china
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published:
2024-04-02
(Crawled : 05:00)
- globenewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-6.49%
|
O:
-2.79%
H:
1.32%
C:
1.18%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.05%
|
O:
-1.14%
H:
0.02%
C:
-1.06%
HCM
|
$16.49
0.8%
0.79%
61K
|
Health Technology
|
-1.17%
|
O:
0.21%
H:
1.49%
C:
-0.06%
treatment
advanced
china
Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy
Published:
2024-03-27
(Crawled : 00:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.26%
|
O:
-0.26%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-6.27%
|
O:
0.49%
H:
0.84%
C:
-0.07%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.89%
|
O:
1.06%
H:
0.0%
C:
0.0%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-7.43%
|
O:
-0.09%
H:
1.42%
C:
1.1%
ibi310
first
cancer
colon
therapy
study
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published:
2024-03-15
(Crawled : 14:30)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.67%
|
O:
0.21%
H:
0.97%
C:
0.7%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-3.84%
|
O:
0.05%
H:
0.14%
C:
-0.93%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.01%
|
O:
-1.58%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-4.52%
|
O:
-0.7%
H:
0.73%
C:
-0.16%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-7.71%
|
O:
-0.07%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.4%
|
O:
-0.02%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
-6.49%
|
O:
-0.27%
H:
1.26%
C:
0.84%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-0.96%
|
O:
0.2%
H:
1.14%
C:
-1.18%
antibody
therapeutics
market
Global Antidiabetics Market 10 Year Forecast Report 2024-2034, by Product Type, by Application, by Distribution Channel and Region
Published:
2024-03-13
(Crawled : 18:00)
- prnewswire.com
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-9.18%
|
O:
-0.64%
H:
0.94%
C:
-0.56%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.36%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-3.79%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-10.73%
|
O:
0.41%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.22%
|
O:
-0.04%
H:
0.0%
C:
0.0%
report
distribution
year
global
market
Global IgG Mediated Autoimmune Diseases Biologic Drugs Research Report 2023-2029: Shift Towards Personalized Medicine and Targeted Therapies & Adoption of Biosimilars and Biobetters
Published:
2024-03-13
(Crawled : 01:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.76%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-5.42%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.36%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-3.79%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-8.28%
|
O:
0.59%
H:
0.01%
C:
-1.45%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.22%
|
O:
-0.04%
H:
0.0%
C:
0.0%
report
research
global
Global Angina Pectoris Drugs Market Set for Growth Amid Advancements in Healthcare Infrastructure
Published:
2024-03-11
(Crawled : 23:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
2.12%
|
O:
2.01%
H:
0.0%
C:
-2.01%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.34%
|
O:
1.12%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-7.39%
|
O:
0.02%
H:
0.79%
C:
0.79%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-1.1%
|
O:
0.9%
H:
2.03%
C:
1.89%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-7.32%
|
O:
1.04%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.21%
|
O:
0.01%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
1.3%
|
O:
-0.19%
H:
0.22%
C:
-0.21%
global
set
growth
market
US Healthcare Advertising Market Analysis Report 2024-2032: A $23.5 Billion Industry in 2023 with Insights on Major Players' Sales and Advertising Spend
Published:
2024-03-09
(Crawled : 04:20)
- prnewswire.com
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
sales
report
market
Global Dilated Cardiomyopathy (DCM) Market Report 2024, with Company Profiles of the Top 10 Major Market Players
Published:
2024-03-07
(Crawled : 00:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
5.38%
|
O:
3.21%
H:
0.0%
C:
-1.71%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-5.57%
|
O:
0.08%
H:
0.86%
C:
0.7%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.57%
|
O:
-0.68%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-6.9%
|
O:
-0.02%
H:
0.0%
C:
-2.29%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-10.67%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.74%
|
O:
-0.08%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.57%
|
O:
-0.03%
H:
0.62%
C:
0.5%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-1.44%
|
O:
-0.02%
H:
1.37%
C:
0.34%
company
report
global
market
Global Glucagon-Like Peptide 1 (GLP-1) Agonist Market Analysis Report 2024: A $133.5 Billion in 2030 Featuring Eli Lilly and Co, Pfizer, Sanofi, AstraZeneca, Boehringer Ingelheim, and Novo Nordisk
Published:
2024-02-27
(Crawled : 01:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
4.78%
|
O:
-1.72%
H:
2.54%
C:
2.54%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-5.91%
|
O:
-2.2%
H:
2.39%
C:
1.34%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.14%
|
O:
-0.94%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.97%
|
O:
0.01%
H:
0.79%
C:
0.6%
report
agonist
global
market
United States Pharmaceuticals Market Size to Surpass US$ 1,068.02 Billion by 2030 | Exhibiting a CAGR of 8.6% Says CoherentMI
Published:
2024-02-22
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.97%
|
O:
0.37%
H:
0.58%
C:
0.58%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.21%
|
O:
0.89%
H:
0.4%
C:
0.17%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-5.63%
|
O:
0.57%
H:
0.47%
C:
-0.58%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-4.68%
|
O:
0.14%
H:
1.01%
C:
0.51%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-5.85%
|
O:
0.29%
H:
0.93%
C:
0.47%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.37%
|
O:
0.97%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-8.27%
|
O:
0.65%
H:
1.35%
C:
0.41%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-5.7%
|
O:
0.47%
H:
2.0%
C:
0.93%
pharmaceuticals
market
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published:
2024-02-22
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-5.87%
|
O:
0.14%
H:
0.0%
C:
-0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.13%
|
O:
0.26%
H:
1.36%
C:
1.36%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
7.24%
|
O:
-0.85%
H:
1.12%
C:
0.43%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.14%
|
O:
0.92%
H:
0.0%
C:
0.0%
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
26.78%
|
O:
1.46%
H:
0.44%
C:
0.44%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-14.57%
|
O:
-0.27%
H:
0.0%
C:
-1.17%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-10.18%
|
O:
-0.2%
H:
0.14%
C:
-0.48%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.0%
|
O:
-0.06%
H:
0.46%
C:
0.29%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-5.22%
|
O:
-0.69%
H:
1.42%
C:
1.22%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-2.63%
|
O:
2.37%
H:
1.51%
C:
0.79%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-3.89%
|
O:
-0.65%
H:
1.63%
C:
1.48%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-5.63%
|
O:
-0.88%
H:
1.46%
C:
1.13%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.76%
|
O:
1.67%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
5.32%
|
O:
-2.81%
H:
2.08%
C:
1.38%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-5.13%
|
O:
-0.35%
H:
1.15%
C:
0.96%
lung
reach
cancer
cell
diagnostics
therapy
market
Biosimilar Hormones Global Market Report 2024 - Niche Sectors Record Notable Market Contributions
Published:
2024-02-14
(Crawled : 03:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-2.24%
|
O:
0.38%
H:
2.44%
C:
1.54%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
0.28%
|
O:
-1.1%
H:
0.0%
C:
0.0%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-14.24%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-7.42%
|
O:
-0.21%
H:
0.34%
C:
0.07%
biosimilar
report
global
market
Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published:
2024-02-14
(Crawled : 02:00)
- prnewswire.com
LZAGF
|
$563.5
-19.1%
6
|
Health Technology
|
9.6%
|
O:
3.14%
H:
1.92%
C:
1.92%
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-3.81%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
10.28%
|
O:
0.87%
H:
0.21%
C:
-2.23%
LZAGY
|
$55.65
0.02%
32K
|
Professional, Scientific, and T...
|
11.08%
|
O:
4.07%
H:
1.53%
C:
1.45%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
1.15%
|
O:
0.56%
H:
1.3%
C:
1.22%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.67%
|
O:
0.42%
H:
1.04%
C:
0.97%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.21%
|
O:
-0.91%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-3.96%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-2.24%
|
O:
0.38%
H:
2.44%
C:
1.54%
BAX
|
$39.47
-0.45%
0.0%
2.8M
|
Health Technology
|
-0.38%
|
O:
0.33%
H:
0.63%
C:
-0.28%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-4.61%
|
O:
-0.73%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.7%
|
O:
-0.83%
H:
0.66%
C:
0.38%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
0.28%
|
O:
-1.1%
H:
0.0%
C:
0.0%
GLPG
|
News
|
$29.095
0.64%
0.64%
87K
|
Health Technology
|
-25.55%
|
O:
-1.72%
H:
1.8%
C:
1.59%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-14.24%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
12.32%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-7.42%
|
O:
-0.21%
H:
0.34%
C:
0.07%
report
global
protein
growth
market
Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published:
2024-02-14
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-3.81%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
10.28%
|
O:
0.87%
H:
0.21%
C:
-2.23%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-3.96%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-2.24%
|
O:
0.38%
H:
2.44%
C:
1.54%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
-5.23%
|
O:
0.56%
H:
0.49%
C:
-0.12%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
0.28%
|
O:
-1.1%
H:
0.0%
C:
0.0%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-14.24%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
12.32%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-7.42%
|
O:
-0.21%
H:
0.34%
C:
0.07%
disease
report
treatment
expansion
global
infections
market
Animal Therapeutics and Diagnostics Global Market Report 2024 - Dermatological Disease Management in Animals to Propel Market Growth
Published:
2024-02-13
(Crawled : 23:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
ZTS
|
News
|
$146.5
-4.32%
0.0%
6.2M
|
Health Technology
|
-20.16%
|
O:
0.93%
H:
0.7%
C:
-0.6%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
1.15%
|
O:
0.56%
H:
1.3%
C:
1.22%
QGEN
|
$40.0
1.34%
0.0%
1.1M
|
Health Technology
|
-6.67%
|
O:
-1.14%
H:
1.3%
C:
1.2%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-2.24%
|
O:
0.38%
H:
2.44%
C:
1.54%
ELAN
|
$12.95
-4.57%
0.0%
5.7M
|
Process Industries
|
-17.46%
|
O:
1.53%
H:
1.16%
C:
0.82%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
0.28%
|
O:
-1.1%
H:
0.0%
C:
0.0%
QGEN
|
$40.0
1.34%
0.0%
1.1M
|
Health Technology
|
-6.67%
|
O:
-1.14%
H:
1.3%
C:
1.2%
PAHC
|
$13.31
2.07%
2.03%
130K
|
Health Technology
|
17.39%
|
O:
1.32%
H:
4.7%
C:
4.09%
NEOG
P
|
$11.6
-2.77%
-2.84%
1.9M
|
Health Technology
|
-29.38%
|
O:
-0.24%
H:
4.39%
C:
3.29%
management
propel
disease
report
animal
global
animals
dermatological
diagnostics
therapeutics
growth
market
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-1.6%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
12.87%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-12.2%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.48%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.14%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-5.55%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-3.21%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-1.49%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-1.65%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-3.85%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$14.08
-0.99%
-0.99%
470K
|
Health Technology
|
-22.73%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
-5.79%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
0.22%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-5.43%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-9.49%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-20.58%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
11.63%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$360.11
0.47%
0.47%
330K
|
Health Technology
|
-8.27%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-8.66%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published:
2024-02-12
(Crawled : 15:30)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
10.28%
|
O:
-0.57%
H:
0.04%
C:
-1.74%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.6%
|
O:
-1.46%
H:
1.04%
C:
0.97%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-1.87%
|
O:
0.09%
H:
0.0%
C:
-0.48%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-1.77%
|
O:
0.02%
H:
0.46%
C:
-0.14%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-4.91%
|
O:
-0.83%
H:
0.7%
C:
-0.27%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.43%
|
O:
-0.64%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-0.64%
|
O:
-0.86%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
10.1%
|
O:
-1.77%
H:
0.46%
C:
0.41%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-7.62%
|
O:
-0.4%
H:
1.6%
C:
1.54%
report
health
treatment
care
global
market
← Previous
1
2
3
4
5
6
7
8
9
…
12
13
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
GBR
|
$1.42
31.48%
11.27%
990K
|
Energy Minerals
KUKE
|
$2.88
2.49%
7.64%
360K
|
CXM
4
|
$11.34
-0.44%
4.27%
1.7M
|
Information
PVL
4
|
$1.47
-0.68%
4.08%
77K
|
Energy Minerals
RNR
4
|
$224.74
0.85%
3.52%
310K
|
Finance
PZG
|
$0.4431
0.48%
2.91%
150K
|
Non-Energy Minerals
SIX
|
$23.45
-0.55%
0.68%
650K
|
Consumer Services
KNSL
4
|
$451.81
-0.02%
0.49%
140K
|
Finance
SENS
|
$0.3992
-4.04%
0.45%
2M
|
Electronic Technology
LAD
|
$261.0
0.25%
0.4%
230K
|
Retail Trade
Your saved searches
Save your searches and get alerts when important news are released.